GSK
3 years ago ⋅ English ⋅ 3 min read
Newsroom
GSK Consumer Healthcare commits to make over a billion toothpaste tubes recyclable by 2025 as part of its ongoing sustainability journey

For media and investors onlyGSK Consumer Healthcare (GSKCH), the world-leading consumer healthcare business, announced today that it is partnering with two global packaging suppliers to... Read More
GSK
3 years ago ⋅ English ⋅ 9 min read
Newsroom
GSK and Vir Biotechnology announce the start of the EMA rolling review of VIR-7831 (sotrovimab) for the early treatment of COVID-19

For media and investors onlyIssued: London UK and San Francisco US- Rolling review will evaluate sotrovimab in adults and adolescents with COVID-19 who do not require oxygen supplementa... Read More
GSK
3 years ago ⋅ English ⋅ 7 min read
Newsroom
European Commission approves Benlysta for adult patients with active lupus nephritis

First and only biologic approved for both systemic lupus erythematosus and lupus nephritisFor media and investors onlyGlaxoSmithKline plc (GSK) today announced the European Commission h... Read More
GSK
3 years ago ⋅ English ⋅ 6 min read
Newsroom
ViiV Healthcare initiates rolling submission of new drug application with US FDA for long-acting cabotegravir for prevention of HIV

For media and investors onlyViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi Limited as shareh... Read More
GSK
3 years ago ⋅ English ⋅ 4 min read
Newsroom
GSK delivers Q1 sales of £7.4 billion -18% AER, -15% CER Total EPS 21.5p, -32% AER, -25% CER; Adjusted EPS 22.9p -39% AER, -33% CER

For media and investors onlyQ1 performance reflects expected year-on-year impact and disruption from COVID-19On track to create New GSK and New Consumer Healthcare company in 2022Full r... Read More
GSK
3 years ago ⋅ English ⋅ 9 min read
Newsroom
European Commission approves GSK’s JEMPERLI (dostarlimab), the first anti-PD-1 therapy approved for recurrent or advanced endometrial cancer

For media and investors onlyGlaxoSmithKline (LSE/NYSE: GSK) plc today announced the European Commission has granted conditional marketing authorisation for JEMPERLI (dostarlimab), a pro... Read More